Our operations are aligned with the highest standards of global pharmaceutical regulation, ensuring trust and safety across every stage of production.
Global Recognition
- India hosts the largest number of USFDA‑approved manufacturing units outside the United States both for APIs and formulations . India has specialised in oncology APIs and formulations far ahead of competitions from other countries
- This achievement reflects our commitment to international quality benchmarks.
Stringent Oversight
- The Central Drugs Standard Control Organization (CDSCO) serves as India’s nodal regulatory authority.
- CDSCO enforces robust laws harmonized with global best practices to safeguard patient health.
Schedule M Amendments
- Recent updates to Schedule M of the Drugs and Cosmetics Act highlight the regulator’s determination to strengthen compliance frameworks.
- These changes reinforce product integrity and elevate India’s position as a trusted global healthcare partner.
Commitment to Patient Safety
- Every regulation and compliance measure is designed with the ultimate patient in mind.
- Our processes prioritize transparency, accountability, and continuous improvement.